Second generation calcium channel blockers in the treatment of chronic heart failure: Are they any better than their predecessors?*
- 1 November 1989
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 14 (5) , 1339-1342
- https://doi.org/10.1016/0735-1097(89)90438-5
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial InfarctionNew England Journal of Medicine, 1988
- Effect of the second-generation calcium channel blocker nisoldipine on left ventricular contractility in cardiac failureAmerican Heart Journal, 1988
- ???Second Generation??? Dihydropyridine Calcium AntagonistsDrugs, 1987
- Prevention and Reversal of Nitrate Tolerance in Patients with Congestive Heart FailureNew England Journal of Medicine, 1987
- Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failureAmerican Heart Journal, 1986
- Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failureThe American Journal of Cardiology, 1985
- Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.Circulation, 1985
- Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis.Circulation, 1982
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982